AU6125396A - Serum-free media for primitive hematopoietic cells and metho ds of use thereof - Google Patents

Serum-free media for primitive hematopoietic cells and metho ds of use thereof

Info

Publication number
AU6125396A
AU6125396A AU61253/96A AU6125396A AU6125396A AU 6125396 A AU6125396 A AU 6125396A AU 61253/96 A AU61253/96 A AU 61253/96A AU 6125396 A AU6125396 A AU 6125396A AU 6125396 A AU6125396 A AU 6125396A
Authority
AU
Australia
Prior art keywords
metho
serum
hematopoietic cells
free media
primitive hematopoietic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61253/96A
Inventor
Wallace W. Tanaka
Mary C. Tsao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Systemix Inc
Original Assignee
Sandoz AG
Systemix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Systemix Inc filed Critical Sandoz AG
Publication of AU6125396A publication Critical patent/AU6125396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU61253/96A 1995-06-07 1996-06-06 Serum-free media for primitive hematopoietic cells and metho ds of use thereof Abandoned AU6125396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US484514 1990-02-23
US48451495A 1995-06-07 1995-06-07
PCT/EP1996/002454 WO1996040866A1 (en) 1995-06-07 1996-06-06 Serum-free media for primitive hematopoietic cells and methods of use thereof

Publications (1)

Publication Number Publication Date
AU6125396A true AU6125396A (en) 1996-12-30

Family

ID=23924463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61253/96A Abandoned AU6125396A (en) 1995-06-07 1996-06-06 Serum-free media for primitive hematopoietic cells and metho ds of use thereof

Country Status (2)

Country Link
AU (1) AU6125396A (en)
WO (1) WO1996040866A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0834556A1 (en) * 1996-09-25 1998-04-08 Academisch Ziekenhuis Leiden Methods for culturing cells
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
ATE342348T1 (en) 1998-11-09 2006-11-15 Consorzio Per La Gestione Del SERUM-FREE MEDIUM FOR CHONDROCYTE-LIKE CELLS
US6248585B1 (en) 1998-11-19 2001-06-19 Thomas Jefferson University Compositions for preserving haptenized tumor cells for use in vaccines
US6534280B1 (en) * 1999-04-15 2003-03-18 Padmanabhan P. Nair Noninvasive detection of colorectal cancer and other gastrointestinal pathology
AT409379B (en) 1999-06-02 2002-07-25 Baxter Ag MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE
JP4481652B2 (en) * 2002-02-12 2010-06-16 レイベン バイオテクノロジーズ，インコーポレイティド Human fetal bladder-derived epithelial cells
AU2003249990B2 (en) 2002-07-09 2007-06-28 Takeda Pharmaceutical Company Limited Animal protein free media for cultivation of cells
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
CN100362098C (en) * 2005-09-29 2008-01-16 华东理工大学 Non-serum culture medium for multiple animal cell large-scale culture
PT1974014T (en) 2006-01-04 2017-05-26 Baxalta Inc Oligopeptide-free cell culture media
WO2007108689A2 (en) * 2006-03-21 2007-09-27 Stichting Skeletal Tissue Engineering Method for induction of differentiation of stem and progenitor cells
AU2007230902B2 (en) * 2006-03-24 2013-03-14 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
CA2666972C (en) 2006-10-20 2015-12-29 Children's Medical Center Corporation Method to enhance tissue regeneration
FI20075417A0 (en) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Formulations and methods for culturing embryonic stem cells
AT505008B1 (en) * 2007-06-06 2008-10-15 Angewandte Biotechnologie Gmbh METHOD FOR CULTURING TISSUE CELLS FROM NON-EMBRYOONAL PLURIPOTENTIAL CELLS OF MESENCHYMAL ORIGIN
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
US9056085B2 (en) 2009-02-03 2015-06-16 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
EP2554658A4 (en) * 2010-03-31 2014-01-01 Oriental Yeast Co Ltd Method for culturing cells in system containing laminin-5
CA2857640C (en) 2011-12-02 2021-11-16 Fate Therapeutics, Inc. Enhanced stem cell composition
EP3381456A1 (en) 2011-12-02 2018-10-03 Fate Therapeutics, Inc. Improved methods for treating ischemia
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
CN105102610B (en) * 2013-03-28 2020-10-13 通用电气健康护理生物科学股份公司 Method for cell culture
US9944895B2 (en) 2013-03-28 2018-04-17 Ge Healthcare Bio-Sciences Ab Method for cell culture
CN111088217B (en) * 2019-12-20 2023-03-03 广东博溪生物科技有限公司 Cell culture medium, cell culture kit and cell culture method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548211B1 (en) * 1983-06-29 1985-10-18 Choay Sa PROCESS FOR PRODUCING TISSUE ACTIVATOR OF PLASMINOGEN AND ACTIVATOR OBTAINED THEREBY
DE3801236A1 (en) * 1988-01-18 1989-07-27 Boehringer Mannheim Gmbh PENTOSANE SULFATE MEDIUM
WO1990002175A1 (en) * 1988-08-16 1990-03-08 Novo Nordisk A/S A method of producing polypeptides by culturing eukaryotic cells in the presence of protease inhibitors
DE550760T1 (en) * 1991-07-18 1994-02-03 Fuji Yakuhin Kogyo Kk SERUM-FREE TISSUE CULTURE MEDIA CONTAINING A TISSUE INHIBITOR OF METAL PROTEINASE AND METHODS OF CELL GROWTH.
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
AU702871B2 (en) * 1993-08-23 1999-03-11 Nexell Therapeutics Inc. (In vitro) growth of neutrophil and megakaryocyte precursors in serum-free media
US5512477A (en) * 1994-04-21 1996-04-30 Genzyme Corporation Serum-free medium supplement

Also Published As

Publication number Publication date
WO1996040866A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU6125396A (en) Serum-free media for primitive hematopoietic cells and metho ds of use thereof
AU1692495A (en) Coated abrasives and methods of making same
AU6898996A (en) Compositions and methods for growth promotion
AU3442495A (en) Liquiflash particles and method of making same
AU4244596A (en) Fluorocarbon containing coatings, compositions and methods of use
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
AU4370096A (en) Hydrocarbyl containing coatings, compositions and methods of use
AU1644295A (en) Cell culture substrates and methods of use
AU2757097A (en) Method of coating and compositions for use therein
AU3976297A (en) Intraluminal delivery of tissue lysing medium
AU4266596A (en) Composition and use
AU3875395A (en) Fluid containers and methods of manufacture thereof
AU6032296A (en) Coanda effect gene delivery instrument and method of use
AU7998594A (en) Coated pipes and methods of making them
AU5147996A (en) Gene therapy for transplantation and inflammatory or thrombo tic conditions
AU7326796A (en) Stable chicken b-cell line and method of use thereof
AU4623196A (en) Process and composition for cleaning surfaces
AU2762895A (en) Lubricants with molybdenum containing compositions and methods of using the same
AU2359895A (en) Serum-free medium supplement
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU4468093A (en) Composition and methods for the generation of bone
AU7210394A (en) Totipotent hematopoietic stem cell receptors and their ligands
AU5300594A (en) Medium for in vitro fertilization and method of in vitro fertilization
AU1685895A (en) Hematopoietic cell expansion and transplantation methods
AU3139493A (en) Totipotent hematopoietic stem cell receptors and their ligands